T
TILRAY INC
NASDAQ: TLRY (Tilray Brands, Inc.)
Last update: 19 hours ago1.56
0.02 (1.30%)
| Previous Close | 1.54 |
| Open | 1.50 |
| Volume | 67,507,745 |
| Avg. Volume (3M) | 80,820,923 |
| Market Cap | 1,751,666,432 |
| Price / Sales | 1.75 |
| Price / Book | 1.18 |
| 52 Weeks Range | |
| Earnings Date | 8 Jan 2026 |
| Profit Margin | -114.40% |
| Operating Margin (TTM) | -16.76% |
| Diluted EPS (TTM) | -1.10 |
| Quarterly Revenue Growth (YOY) | -1.40% |
| Total Debt/Equity (MRQ) | 12.73% |
| Current Ratio (MRQ) | 2.62 |
| Operating Cash Flow (TTM) | -51.09 M |
| Levered Free Cash Flow (TTM) | 26.37 M |
| Return on Assets (TTM) | -1.63% |
| Return on Equity (TTM) | -30.73% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Drug Manufacturers - Specialty & Generic (US) | Bullish | Bullish |
| Drug Manufacturers - Specialty & Generic (Global) | Bullish | Bullish | |
| Stock | Tilray Brands, Inc. | Bullish | Mixed |
AIStockmoo Score
1.5
| Analyst Consensus | 1.5 |
| Insider Activity | NA |
| Price Volatility | -4.5 |
| Technical Moving Averages | 5.0 |
| Technical Oscillators | 4.0 |
| Average | 1.50 |
|
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure consists of CBD products and alcohol. |
|
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Investment Style | Small Value |
| % Held by Insiders | 0.69% |
| % Held by Institutions | 10.10% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Luxor Capital Group, Lp | 30 Jun 2025 | 2,343,000 |
| Ausdal Financial Partners, Inc. | 30 Jun 2025 | 2,265,416 |
| Swiss National Bank | 30 Jun 2025 | 1,928,138 |
| 52 Weeks Range | ||
| Median | 2.00 (28.21%) | |
| Total | 1 Buy | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Jefferies | 25 Aug 2025 | 2.00 (28.21%) | Buy | 1.39 |
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |